Goldman Sachs’s Ovid Therapeutics OVID Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $93.6K | Buy |
|
|||||
|
2025
Q1 | $32.6K | Sell |
|
|||||
|
2024
Q4 | $185K | Buy |
|
|||||
|
2024
Q3 | $154K | Buy |
|
|||||
|
2024
Q2 | $97.6K | Buy |
|
|||||
|
2024
Q1 | $180K | Sell |
|
|||||
|
2023
Q4 | $199K | Buy |
|
|||||
|
2023
Q3 | $218K | Sell |
|
|||||
|
2023
Q2 | $217K | Buy |
|
|||||
|
2023
Q1 | $28.8K | Sell |
|
|||||
|
2022
Q4 | $28.2K | Sell |
|
|||||
|
2022
Q3 | $67K | Sell |
|
|||||
|
2022
Q2 | $94K | Sell |
|
|||||
|
2022
Q1 | $143K | Sell |
|
|||||
|
2021
Q4 | $158K | Sell |
|
|||||
|
2021
Q3 | $328K | Sell |
|
|||||
|
2021
Q2 | $444K | Sell |
|
|||||
|
2021
Q1 | $3.02M | Buy |
|
|||||
|
2020
Q4 | $1.1M | Buy |
|
|||||
|
2020
Q3 | $296K | Sell |
|
|||||
|
2020
Q2 | $845K | Sell |
|
|||||
|
2020
Q1 | $406K | Buy |
|
|||||
|
2019
Q4 | $355K | Buy |
|
|||||
|
2019
Q3 | $116K | Sell |
|
|||||
|
2019
Q2 | $87K | Buy |
|
|||||
|
2019
Q1 | $42K | Buy |
|
|||||
|
2018
Q4 | $38K | Sell |
|
|||||
|
2018
Q3 | $153K | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $105K | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $923K | Buy |
|